TGAN / Transphorm, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Transphorm, Inc.
US ˙ NasdaqCM ˙ US89386L1008
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier5.772.213 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Transphorm, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TGAN / Transphorm, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-07-21 KKR Phorm Investors L.P. 1.735.988 3,3000 1.735.988 3,3000 5.728.760 335 5.1000 3.124.779 54,55
2021-11-05 KKR Phorm Investors L.P. 500.000 500.000
2021-11-05 KKR Phorm Investors L.P. 1.000.000 5,0000 1.000.000 5,0000 5.000.000
2020-02-12 Tompkins Mark N. 25.000 4,0000 25.000 4,0000 100.000
2020-02-12 KKR Phorm Investors L.P. 1.250.000 4,0000 1.250.000 4,0000 5.000.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TGAN / Transphorm, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TGAN / Transphorm, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-06-20 KKR Phorm Investors L.P. 24.411.968 5,1000 24.411.968 5,1000 124.501.037 0 5.1000 1 0,00
2024-02-29 Parikh Primit 6.000 4,8010 6.000 4,8010 28.806
2022-11-30 Parikh Primit 1.648 5,6340 1.648 5,6340 9.285
2022-11-29 Parikh Primit 1.852 6,0350 1.852 6,0350 11.177
2022-11-23 Parikh Primit 2.000 6,6410 2.000 6,6410 13.282
2022-11-17 Parikh Primit 8.927 5,6740 8.927 5,6740 50.652
2022-11-17 RIVAS MARIO 3.571 5,6740 3.571 5,6740 20.262
2022-11-17 Mishra Umesh 1.785 5,6740 1.785 5,6740 10.128
2022-11-17 McAulay Cameron 2.806 5,6740 2.806 5,6740 15.921
2022-02-28 Parikh Primit 3.000 7,3770 3.000 7,3770 22.131

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TGAN / Transphorm, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-06-20 2024-06-20 4 KKR Phorm Investors L.P. See footnotes TGAN Common Stock S - Sale I 5,1000 -24.411.968 -124.501 0
2024-06-20 2024-06-20 4 Smales Kelly TGAN Common Stock D - Sale to Issuer D -69.677 0
2024-06-20 2024-06-20 4 MCFARLAND KATHARINA G. TGAN Common Stock D - Sale to Issuer D -81.323 0
2024-06-20 2024-06-20 4 Moreland Cynthia J TGAN Common Stock D - Sale to Issuer D -82.106 0
2024-06-20 2024-06-20 4 Humphreys Michael Julian TGAN Common Stock D - Sale to Issuer D -91.037 0
2024-06-20 2024-06-20 4 McAulay Cameron TGAN Common Stock D - Sale to Issuer D -182.048 0
2024-06-20 2024-06-20 4 Mishra Umesh TGAN Common Stock D - Sale to Issuer D -359.720 0
2024-06-20 2024-06-20 4 Parikh Primit TGAN Common Stock D - Sale to Issuer D -489.310 0
2024-05-24 2024-05-22 4 Smales Kelly TGAN Common Stock S - Sale D 4,8920 -3.996 -20 69.677
2024-05-24 2024-05-22 4 MCFARLAND KATHARINA G. TGAN Common Stock S - Sale D 4,8920 -3.996 -20 81.323
2024-04-26 2024-04-24 4 Smales Kelly TGAN Common Stock S - Sale D 4,8500 -475 -2 73.673
2024-04-26 2024-04-24 4 MCFARLAND KATHARINA G. TGAN Common Stock S - Sale D 4,8500 -840 -4 85.319
2024-04-23 2024-04-20 4 Moreland Cynthia J TGAN Common Stock A - Award D 1.043 82.106
2024-04-23 2024-04-20 4 Smales Kelly TGAN Common Stock A - Award D 1.356 74.148
2024-04-23 2024-04-20 4 Humphreys Michael Julian TGAN Common Stock A - Award D 1.409 91.037
2024-04-23 2024-04-20 4 MCFARLAND KATHARINA G. TGAN Common Stock A - Award D 2.400 86.159
2024-04-05 2024-04-04 4 Smales Kelly TGAN Common Stock S - Sale D 4,9000 -766 -4 72.792
2024-03-04 2024-02-29 4 Parikh Primit TGAN Common Stock S - Sale D 4,8010 -6.000 -29 489.310
2024-03-01 2024-02-28 4 Smales Kelly TGAN Common Stock S - Sale D 4,8110 -3.996 -19 73.558
2024-03-01 2024-02-28 4 MCFARLAND KATHARINA G. TGAN Common Stock S - Sale D 4,8110 -3.996 -19 83.759
2024-01-26 2024-01-24 4 Smales Kelly TGAN Common Stock S - Sale D 4,8210 -471 -2 77.554
2024-01-26 2024-01-24 4 MCFARLAND KATHARINA G. TGAN Common Stock S - Sale D 4,8200 -833 -4 87.755
2024-01-23 2024-01-20 4 Moreland Cynthia J TGAN Common Stock A - Award D 1.035 81.063
2024-01-23 2024-01-20 4 Smales Kelly TGAN Common Stock A - Award D 1.345 78.025
2024-01-23 2024-01-20 4 Humphreys Michael Julian TGAN Common Stock A - Award D 1.397 89.628
2024-01-23 2024-01-20 4 MCFARLAND KATHARINA G. TGAN Common Stock A - Award D 2.380 88.588
2024-01-05 2024-01-04 4 Smales Kelly TGAN Common Stock S - Sale D 3,9000 -766 -3 76.680
2024-01-03 2024-01-02 4 Smales Kelly TGAN Common Stock S - Sale D 3,6100 -2.187 -8 77.446
2024-01-03 2024-01-01 4 Parikh Primit TGAN Common Stock F - Taxes D 3,6500 -6.780 -25 495.310
2024-01-03 2024-01-01 4 McAulay Cameron TGAN Common Stock F - Taxes D 3,6500 -5.650 -21 182.048
2024-01-03 2024-01-01 4 Mishra Umesh TGAN Common Stock F - Taxes D 3,6500 -3.390 -12 359.720
2023-11-27 2023-11-22 4 Smales Kelly TGAN Common Stock S - Sale D 2,6280 -3.995 -10 79.633
2023-11-27 2023-11-22 4 MCFARLAND KATHARINA G. TGAN Common Stock S - Sale D 2,7030 -3.995 -11 86.208
2023-11-21 2023-11-20 4 MCFARLAND KATHARINA G. TGAN Common Stock S - Sale D 3,0100 -3.515 -11 90.203
2023-11-21 2023-11-17 4 Mishra Umesh TGAN Common Stock F - Taxes D 2,7700 -1.614 -4 363.110
2023-11-21 2023-11-17 4 Parikh Primit TGAN Common Stock F - Taxes D 2,7700 -8.069 -22 502.090
2023-11-21 2023-11-17 4 McAulay Cameron TGAN Common Stock F - Taxes D 2,7700 -2.536 -7 187.698
2023-11-21 2023-11-20 4 Smales Kelly TGAN Common Stock S - Sale D 2,8880 -656 -2 83.628
2023-11-21 2023-11-17 4 Smales Kelly TGAN Common Stock S - Sale D 2,8180 -3.227 -9 84.284
2023-10-24 2023-10-20 4 Smales Kelly TGAN Common Stock A - Award D 2.708 87.511
2023-10-24 2023-10-20 4 Moreland Cynthia J TGAN Common Stock A - Award D 2.083 80.028
2023-10-24 2023-10-20 4 Humphreys Michael Julian TGAN Common Stock A - Award D 2.812 88.231
2023-10-24 2023-10-20 4 MCFARLAND KATHARINA G. TGAN Common Stock A - Award D 4.791 93.718
2023-10-13 2023-10-11 4 Smales Kelly TGAN Common Stock A - Award D 2.968 84.803
2023-10-13 2023-10-11 4 Smales Kelly TGAN Common Stock A - Award D 45.662 81.835
2023-10-13 2023-10-11 4 Moreland Cynthia J TGAN Common Stock A - Award D 2.283 77.945
2023-10-13 2023-10-11 4 Moreland Cynthia J TGAN Common Stock A - Award D 45.662 75.662
2023-10-13 2023-10-11 4 MCFARLAND KATHARINA G. TGAN Common Stock A - Award D 5.251 88.927
2023-10-13 2023-10-11 4 MCFARLAND KATHARINA G. TGAN Common Stock A - Award D 45.662 83.676
2023-10-13 2023-10-11 4 Humphreys Michael Julian TGAN Common Stock A - Award D 3.082 85.419
2023-10-13 2023-10-11 4 Humphreys Michael Julian TGAN Common Stock A - Award D 45.662 82.337
2023-09-01 2023-08-30 4 Mishra Umesh TGAN Common Stock A - Award D 172.800 364.724
2023-09-01 2023-08-30 4 McAulay Cameron TGAN Common Stock A - Award D 105.600 190.234
2023-09-01 2023-08-30 4 Parikh Primit TGAN Common Stock A - Award D 288.000 510.159
2023-07-25 2023-07-21 4 Parikh Primit TGAN Common Stock M - Exercise D 3,3000 3.100 10 222.159
2023-07-25 2023-07-21 4 Smales Kelly TGAN Common Stock M - Exercise D 3,3000 1.173 4 36.173
2023-07-25 2023-07-21 4 Mishra Umesh TGAN Common Stock M - Exercise D 3,3000 7.500 25 191.924
2023-07-25 2023-07-21 4 MCFARLAND KATHARINA G. TGAN Common Stock M - Exercise D 3,3000 3.014 10 38.014
2023-07-25 2023-07-21 4 McAulay Cameron TGAN Common Stock M - Exercise D 3,3000 3.031 10 84.634
2023-07-25 2023-07-21 4 Humphreys Michael Julian TGAN Common Stock M - Exercise D 3,3000 1.675 6 36.675
2023-07-25 2023-07-21 4 KKR Phorm Investors L.P. See footnotes TGAN Common Stock P - Purchase I 3,3000 1.735.988 5.729 24.411.968
2023-07-05 2023-07-01 4 Parikh Primit TGAN Common Stock F - Taxes D 3,4000 -14.360 -49 219.059
2023-07-05 2023-07-01 4 McAulay Cameron TGAN Common Stock F - Taxes D 3,4000 -8.605 -29 81.603
2023-07-05 2023-07-01 4 Mishra Umesh TGAN Common Stock F - Taxes D 3,4000 -14.360 -49 184.424
2023-01-04 2023-01-01 4 RIVAS MARIO TGAN Common Stock F - Taxes D 5,4400 -12.533 -68 122.213
2023-01-04 2023-01-01 4 RIVAS MARIO TGAN Common Stock A - Award D 16.544 134.746
2023-01-04 2023-01-01 4 Parikh Primit TGAN Common Stock F - Taxes D 5,4400 -16.183 -88 233.419
2023-01-04 2023-01-01 4 Parikh Primit TGAN Common Stock A - Award D 16.544 249.602
2023-01-04 2023-01-01 4 McAulay Cameron TGAN Common Stock F - Taxes D 5,4400 -10.193 -55 90.208
2023-01-04 2023-01-01 4 McAulay Cameron TGAN Common Stock A - Award D 13.786 100.401
2023-01-04 2023-01-01 4 Mishra Umesh TGAN Common Stock F - Taxes D 5,4400 -16.183 -88 198.784
2023-01-04 2023-01-01 4 Mishra Umesh TGAN Common Stock A - Award D 8.272 214.967
2022-12-01 2022-11-30 4 Parikh Primit TGAN Common Stock S - Sale D 5,6340 -1.648 -9 233.058
2022-12-01 2022-11-29 4 Parikh Primit TGAN Common Stock S - Sale D 6,0350 -1.852 -11 234.706
2022-11-28 2022-11-23 4 Parikh Primit TGAN Common Stock S - Sale D 6,6410 -2.000 -13 236.558
2022-11-28 2022-11-23 4 Parikh Primit TGAN Common Stock M - Exercise D 4,3400 1.000 4 238.558
2022-11-21 2022-11-17 4 McAulay Cameron TGAN Common Stock S - Sale D 5,6740 -2.806 -16 86.615
2022-11-21 2022-11-17 4 Mishra Umesh TGAN Common Stock S - Sale D 5,6740 -1.785 -10 206.695
2022-11-21 2022-11-17 4 RIVAS MARIO TGAN Common Stock S - Sale D 5,6740 -3.571 -20 118.202
2022-11-21 2022-11-17 4 Parikh Primit TGAN Common Stock S - Sale D 5,6740 -8.927 -51 237.558
2022-06-10 2022-02-28 4 Parikh Primit TGAN Common Stock M - Exercise D 4,3400 1.000 4 246.485
2022-06-03 2022-06-01 4 KKR Phorm Investors L.P. See footnotes TGAN Common Stock X - Other I 5,0000 500.000 2.500 22.675.980
2022-03-02 2022-02-28 4 Parikh Primit TGAN Common Stock S - Sale D 7,3770 -3.000 -22 245.485
2022-01-04 2022-01-01 4 RIVAS MARIO TGAN Common Stock F - Taxes D 8,0000 -11.847 -95 121.773
2022-01-04 2022-01-01 4 Mishra Umesh TGAN Common Stock F - Taxes D 8,0000 -15.471 -124 208.480
2022-01-04 2022-01-01 4 Parikh Primit TGAN Common Stock F - Taxes D 8,0000 -15.471 -124 248.485
2022-01-04 2022-01-01 4 McAulay Cameron TGAN Common Stock F - Taxes D 8,0000 -9.719 -78 89.421
2021-12-17 2021-12-15 4 McAulay Cameron TGAN Stock Option (right to buy) A - Award D 7,99 33.000 33.000
2021-12-17 2021-12-15 4 McAulay Cameron TGAN Common Stock A - Award D 22.000 99.140
2021-12-17 2021-12-15 4 Mishra Umesh TGAN Stock Option (right to buy) A - Award D 7,99 21.000 21.000
2021-12-17 2021-12-15 4 Mishra Umesh TGAN Common Stock A - Award D 14.000 223.951
2021-12-17 2021-12-15 4 Parikh Primit TGAN Stock Option (right to buy) A - Award D 7,99 105.000 105.000
2021-12-17 2021-12-15 4 Parikh Primit TGAN Common Stock A - Award D 70.000 263.956
2021-12-17 2021-12-15 4 RIVAS MARIO TGAN Stock Option (right to buy) A - Award D 7,99 42.000 42.000
2021-12-17 2021-12-15 4 RIVAS MARIO TGAN Common Stock A - Award D 28.000 133.620
2021-11-08 2021-11-05 4 KKR Phorm Investors L.P. See footnotes NONE Contractual Right to Purchase Warrant (Right to Buy) P - Purchase I 104.167 104.167
2021-11-08 2021-11-05 4 KKR Phorm Investors L.P. See footnotes NONE Contractual Right to Purchase P - Purchase I 5,00 500.000 500.000
2021-11-08 2021-11-05 4 KKR Phorm Investors L.P. See footnotes NONE Warrant (Right to Buy) P - Purchase I 6,00 208.333 208.333
2021-11-08 2021-11-05 4 KKR Phorm Investors L.P. See footnotes NONE Common Stock P - Purchase I 5,0000 1.000.000 5.000 22.175.980
2021-10-22 2021-10-20 4 Moreland Cynthia J TGAN Stock Option (right to buy) A - Award D 4,40 50.000 50.000
2021-10-22 2021-10-20 4 Moreland Cynthia J TGAN Common Stock A - Award D 30.000 30.000
2021-07-06 2021-07-01 4 Smales Kelly TGAN Stock Option (right to buy) A - Award D 4,50 55.000 55.000
2021-07-06 2021-07-01 4 Smales Kelly TGAN Common Stock A - Award D 35.000 35.000
2021-02-25 2021-02-23 4 Humphreys Michael Julian TGAN Stock Option (right to buy) A - Award D 6,50 55.000 55.000
2021-02-25 2021-02-23 4 Humphreys Michael Julian TGAN Common Stock A - Award D 35.000 35.000
2021-02-25 2021-02-23 4 MCFARLAND KATHARINA G. TGAN Stock Option (right to buy) A - Award D 6,50 55.000 55.000
2021-02-25 2021-02-23 4 MCFARLAND KATHARINA G. TGAN Common Stock A - Award D 35.000 35.000
2020-10-02 2020-09-30 4 KKR Fund Holdings L.P. See footnotes TGAN Common Stock J - Other I 0 21.175.980
2020-08-31 2020-03-26 4/A McAulay Cameron TGAN Stock Option (right to buy) A - Award D 0,00 0 0
2020-08-31 2020-03-26 4/A Mishra Umesh TGAN Stock Option (right to buy) A - Award D 0,00 0 0
2020-08-31 2020-03-26 4/A Parikh Primit TGAN Stock Option (right to buy) A - Award D 0,00 0 0
2020-08-31 2020-03-26 4/A RIVAS MARIO TGAN Stock Option (right to buy) A - Award D 0,00 0 0
2020-08-31 2020-08-27 4 RIVAS MARIO TGAN Common Stock A - Award D 93.120 105.620
2020-08-31 2020-08-27 4 McAulay Cameron TGAN Common Stock A - Award D 74.640 77.140
2020-08-31 2020-08-27 4 Mishra Umesh TGAN Common Stock A - Award D 124.560 209.951
2020-08-31 2020-08-27 4 Parikh Primit TGAN Common Stock A - Award D 124.560 193.956
2020-03-27 2020-03-26 4 RIVAS MARIO NONE Stock Option (right to buy) A - Award D 4,00 121.000 121.000
2020-03-27 2020-03-26 4 Parikh Primit NONE Stock Option (right to buy) A - Award D 4,00 162.000 162.000
2020-03-27 2020-03-26 4 Mishra Umesh NONE Stock Option (right to buy) A - Award D 4,00 162.000 162.000
2020-03-27 2020-03-26 4 McAulay Cameron NONE Stock Option (right to buy) A - Award D 4,00 97.000 97.000
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 3 ROBERTS GEORGE R See footnotes NONE Common Stock I 39.851.960
2020-03-13 2020-02-12 4 KKR Phorm Investors L.P. See footnotes NONE Common Stock P - Purchase I 4,0000 1.250.000 5.000 21.175.980
2020-03-12 3 Parikh Primit NONE Common Stock D 133.792
2020-03-12 3 Parikh Primit NONE Common Stock D 133.792
2020-03-12 3 Parikh Primit NONE Common Stock D 133.792
2020-03-12 2020-02-12 4 RIVAS MARIO NONE Common Stock A - Award D 4,0000 12.500 50 12.500
2020-03-12 2020-02-12 4 Mishra Umesh NONE Common Stock A - Award D 4,0000 2.500 10 85.391
2020-03-12 2020-02-12 4 Parikh Primit NONE Common Stock A - Award D 4,0000 2.500 10 69.396
2020-03-12 2020-02-27 4 McAulay Cameron NONE Common Stock A - Award D 4,0000 2.500 10 2.500
2020-03-12 3 Mishra Umesh NONE Common Stock D 165.782
2020-03-12 3 Mishra Umesh NONE Common Stock D 165.782
2020-03-12 3 Mishra Umesh NONE Common Stock D 165.782
2020-02-25 3/A Wingtech Technology Co. Ltd. NONE Common Stock D 4.000.000
2020-02-24 3 Nexperia B.V. NONE Common Stock D 8.000.000
2020-02-24 3 Nexperia B.V. NONE Common Stock D 8.000.000
2020-02-24 3 Nexperia B.V. NONE Common Stock D 8.000.000
2020-02-14 2020-02-12 4 Tompkins Mark N. NONE Common Stock, par value $0.0001 P - Purchase D 4,0000 25.000 100 1.525.000
2020-02-14 2020-02-12 4 Tompkins Mark N. NONE Common Stock, par value $0.0001 J - Other D -657.699 1.500.000
2020-02-14 2020-02-12 4 Jacobs Ian Seth NONE Common Stock, par value $0.0001 J - Other D -25.000 125.000
2018-09-28 3 Jacobs Ian Seth NONE Common Stock, par value $0.0001 per share D 130.000
2018-09-28 3 Jacobs Ian Seth NONE Common Stock, par value $0.0001 per share D 130.000
2018-09-28 3 Jacobs Ian Seth NONE Common Stock, par value $0.0001 per share D 130.000
2018-09-28 3 Tompkins Mark N. NONE Common Stock, par value $0.0001 per share D 1.870.000
2018-09-28 3 Tompkins Mark N. NONE Common Stock, par value $0.0001 per share D 1.870.000
2018-09-28 3 Tompkins Mark N. NONE Common Stock, par value $0.0001 per share D 1.870.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista